| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.33 | 8e-11 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.83 | 0.0004 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |